Facebook Twitter Gplus YouTube Google Maps RSS
 
 
Home » 2012 » February

Archive for February, 2012:


Accutane Case Filed Timely

Yesterday, the N.J. Supreme Court affirmed that a woman’s lawsuit against Hoffman-LaRoche Inc., the manufacturer of Accutane, was timely.  The plaintiff in the subject lawsuit alleged that Accutane, a medication used to treat acne, caused her to develop ulcerative colitis.  Kendall v. Hoffman-La Roche Inc., No. 066802 (N.J. Sup. Ct.). Kendall was prescribed Accutane from

Read More::

Norgestimate and Ethinyl Estradiol Birth Control Pill Recall

Glenmark Generics Inc. issued a nationwide recall on Norgestimate and Ethinyl Estradiol Birth Control Pills due to the possibility of out of sequence tablets, which could then render the pills ineffective, reports the U.S. Food and Drug Administration (FDA).  Select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the

Read More::

More Patients Harmed by Metal Hip Implants than Leaking Breast Implants

Although the dangers of metal hip implants have been known and documented for decades, hundreds of thousands of people around the world may have been exposed to dangerously high levels of toxic metal from metal hip implants, reveals a BMJ and BBC Newsnight investigation. Hip implants, like breast implants, did not have to undergo any

Read More::

DePuy Hip Sold Overseas After FDA Denied Approval in the US

According to an internal company email, Johnson & Johnson continued to market the DePuy articular surface replacement (ASR) device in Europe and Australia after the U.S. Food and Drug Administration (FDA) rejected the device upon reviewing company studies, which revealed that the device had failed prematurely in significant numbers, requiring a significant number of revision

Read More::

Certain Dementia Medications Increase Death Risk in Elderly Patients

According to a recent study published by the British Medical Journal (BMJ), certain antipsychotic drugs given to elderly nursing home residents for dementia increase the risk of death. More than 75,000 users of antipsychotic drugs, such as Risperdal, Seroquel, Abilify, Haldol, Zyprexa, Geodon and Zeldox, participated in the study .  All participants were over the age

Read More::

Chemotherapy Drug Recalled

Bedford Laboratories recalled three lots of Cytarabine for Injection, USP.   The voluntary market recall was prompted after post-release investigation of the manufacturing area which determined a potential elevated risk of a lack of sterility assurance for these specific lots.  To date, there have been no reports of any adverse events for the lots being recalled.

Read More::

Teva Pays $250 Million to Settle Propofol Hepatitis C Lawsuits

Teva Pharmaceutical Industries Ltd. has agreed to pay more than $250 million to settle more than 80 lawsuits wherein Plaintiffs allege the drugmaker intentionally sold Propofol anesthetic in vials that were large enough to be reused by doctors, which led some colonoscopy patients to develop Hepatitis C. Teva had already settled approximately 120 lawsuits and

Read More::

Johnson & Johnson Recalls Infants’ Tylenol Due to Dosing Difficulty

Johnson & Johnson issued a recall notice on Infant’s Tylenol because some parents have complained that the newly redesigned bottles didn’t work correctly. Johnson & Johnson changed the bottle design in an effort to make measuring doses easier and to limit spillage if the bottle is knocked over.  The new infant Tylenol bottle comes with

Read More::

Recalls this week include play slides, toys, teapots, chainsaws, ottomans

Washington Post by Associated Press Children’s products top this week’s list of recalls. A playground slide lacks a platform at the top. The difficulty of moving from the ladder to the slide has led to falls, and more than a dozen reports of children suffering fractures. Also recalled this week were toy vehicle sets with

Read More::

Zoloft Birth Defect Cases May Be Remanded to State Court

Last month Pfizer, the manufacturer of Zoloft, asked the U.S. Judicial Panel on Multidistrict Litigation to create a Zoloft MDL in the U.S. District Court for the Southern District of New York, for all Zoloft birth defect lawsuits filed in federal court. Pfizer reasoned that an MDL for the Zoloft lawsuits, wherein Plaintiffs allege the

Read More::

 
© Ennis & Ennis, P.A.

Switch to our mobile site